Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions
NCT00694317
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Short Term Treatment of Insomnia
Interventions
DRUG:
Zaleplon
Sponsor
Roxane Laboratories